Albert D Epstein

Title: Albert D Epstein: Innovator in Pharmaceutical Processes

Introduction

Albert D Epstein is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug crystallization and purification. With a total of 2 patents, his work has had a meaningful impact on the industry.

Latest Patents

Epstein's latest patents include a process for the crystallization of losartan and a method for riboflavin purification. The crystallization process for losartan potassium, an angiotensin II antagonist, is crucial for treating hypertension and congestive heart failure. This invention focuses on controlled crystallization utilizing anti-solvent addition combined with massive seeding to achieve the desired crystal morphology and bulk physical properties necessary for successful formulation. The riboflavin purification method involves recovering riboflavin from fermentation broth through a series of steps, including dilution, centrifugation, and optional enzyme treatment, yielding a product suitable for animal feed or further pharmaceutical purification.

Career Highlights

Albert D Epstein is currently associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical technologies.

Collaborations

Throughout his career, Epstein has collaborated with talented individuals such as Erik A Dienemann and Hari Mahadevan. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical field.

Conclusion

Albert D Epstein's contributions to pharmaceutical processes through his patents and work at Merck & Co., Inc. highlight his role as an influential inventor. His innovative approaches to drug crystallization and purification continue to shape the industry and improve healthcare outcomes.